These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5102870)

  • 1. Concurrent administration of phenobarbital and diphenylhydantoin: lack of an interference effect.
    Booker HE; Tormey A; Toussaint J
    Neurology; 1971 Apr; 21(4):383-5. PubMed ID: 5102870
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. A study of the clinical effects.
    Volanschi D; Pintilie C
    Neurol Psychiatr (Bucur); 1978; 16(4):259-69. PubMed ID: 741196
    [No Abstract]   [Full Text] [Related]  

  • 5. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phenobarbital and diphenylhydantoin in the plasma and phenobarbital in the cerebrospinal fluid. I. Studies on the concurrent determination of phenobarbital and diphenylhydantoin in the plasma by ultraviolet spectrophotometry and its clinical application].
    Izumi N
    Nihon Shonika Gakkai Zasshi; 1970 May; 74(5):539-51. PubMed ID: 5464711
    [No Abstract]   [Full Text] [Related]  

  • 9. Variations of serum diphenylhydantoin concentrations in epileptic out-patients.
    Vapaatalo H; Lehtinen L
    Eur Neurol; 1971; 5(5):303-10. PubMed ID: 5133553
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of dose, age, and sex on the serum levels of phenobarbital and diphenylhydantoin in epileptic patients.
    Furlanut M; Benetello P; Testa G; Da Ronch A
    Pharmacol Res Commun; 1978 Jan; 10(1):85-9. PubMed ID: 643894
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
    Driessen O; Höppener R
    Eur Neurol; 1977; 15(3):135-42. PubMed ID: 852469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood levels of phenytoin and phenobarbital in epileptics treated with phenydantin and phenytoinum].
    Rosnowska M; Zieliński JJ; Szukalski B
    Neurol Neurochir Pol; 1978; 12(5):569-73. PubMed ID: 724029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polytherapy and monotherapy in the treatment of patients with epilepsy].
    Petrone F; Cavalcanti S; Turchiaro GG; Rolando G
    Acta Neurol Quad (Napoli); 1981; 42():76-84. PubMed ID: 6791454
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical value of determination of serum concentration of antiepileptics.
    Wang L; Zuo QH; Liu SR; Wang SH
    Chin Med J (Engl); 1984 Mar; 97(3):165-70. PubMed ID: 6432478
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT; Wilkinson GR
    Neurology; 1974 Jul; 24(7):614-23. PubMed ID: 4858085
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polytherapy and monotherapy in the treatment of epileptic patients].
    Petrone F; Cavalcanti S; Turchiaro GG; Rolando G
    Acta Neurol (Napoli); 1981 Feb; 3(1):76-84. PubMed ID: 7246321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma diphenylhydantoin concentration in epileptic patients].
    Herishanu Y; Eylath U
    Harefuah; 1974 Sep; 87(6):251-3. PubMed ID: 4442797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.